4 completed. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
Follow NKTR-102: new trials by email Literature Review of NKTR-102 trials Research Report on NKTR-102
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer Pegylated Irinotecan - Stage IV Non-small Cell Lung Cancer (NSCLC), Recurrent Non-small Cell Lung Cancer (NSCLC) | Phase 2 | Completed | Joel Neal | 27 | 2015-08-01 | 2023-12-12 |
| Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma Etirinotecan pegol - Anaplastic Astrocytomas, Anaplastic Oligodendrogliomas | Phase 2 | Completed | Lawrence Recht | 20 | 2012-07-01 | 2016-02-24 |
| NKTR-102 Versus Irinotecan in Patients With Second-Line, Irinotecan-Naïve, KRAS Mutant, Colorectal Cancer NKTR-102, irinotecan - Colorectal Cancer | Phase 2 | Completed | Nektar Therapeutics | 83 | 2008-12-01 | 2021-07-12 |
| Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer NKTR-102 - Tumor, Breast Cancer | Phase 2 | Completed | Nektar Therapeutics | 70 | 2008-10-01 | 2018-07-09 |
Breast Neoplasms (2) · Astrocytoma (1) · Brain Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Glioblastoma (1) · Neoplasms (1) · Oligodendroglioma (1) · Small Cell Lung Carcinoma (1)
Nektar Therapeutics (2) · Joel Neal (1) · Lawrence Recht (1)
United States (4) · Belgium (2) · United Kingdom (2) · Germany (1) · India (1) · Spain (1)
Alison Hannah, MD (1) · Joel Neal (1) · Lawrence Recht, MD (1)